Finance

Beta
Lists
IMRX:NASDAQ
Immuneering Corp
$4.27
-4.69%
(-0.21) 1D
$4.26
-0.28% (-0.012)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMRX...
Open
$4.46
High
$4.47
Low
$4.20
Mkt. cap
276.26M
Avg. vol.
1.67M
Volume
1.44M
52-wk high
$10.08
52-wk low
$1.67
EPS
-$1.17
Beta
0.38
Shares outstanding
64.70M
No. of employees
55
Open
$4.46
High
$4.47
Low
$4.20
Mkt. cap
276.26M
Avg. vol.
1.67M
Volume
1.44M
52-wk high
$10.08
52-wk low
$1.67
EPS
-$1.17
Beta
0.38
Shares outstanding
64.70M
No. of employees
55
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to IMRX in the past 3 months
Strong Buy
Buy
5
Hold
0
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for IMRX in the last 3 months.
Highest
Current $4.27
$30.00 (+602.58%)
Average
$17.00 (+298.13%)
Lowest
$11.00 (+157.61%)
News stories
From sources across the web
About Immuneering Corp
CEO-
Employees55
Founded2008
Headquarters-
SectorBiotechnology
Websiteimmuneering.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10.45M
10.87M
9.25M
10.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.30M
4.51M
4.49M
4.68M
Operating expense
14.76M
15.38M
13.75M
15.34M
Total operating expenses
14.76M
15.38M
13.75M
15.34M
Operating income
-14.76M
-15.38M
-13.75M
-15.34M
Other non operating income
-
-
155.92K
109.01K
EBT including unusual items
-14.43M
-14.96M
-11.58M
-13.46M
EBT excluding unusual items
-14.43M
-14.96M
-11.74M
-13.87M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14.43M
-14.96M
-11.58M
-13.46M
Net profit margin
-
-
-
-
Earnings per share
-0.40
-0.38
-0.18
-0.21
Interest and investment income
324.01K
415.83K
1.86M
1.36M
Interest expense
-
-
-
-
Net interest expenses
324.01K
415.83K
1.86M
1.36M
Depreciation and amortization charges
-
-
-
-
EBITDA
-14.67M
-15.29M
-13.67M
-15.25M
Gain or loss from assets sale
-
-
2.09K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer